“The Concentration and Type of Monoclonal Protein and Their Impact on Clinical Severity in Patients With Symptomatic Myeloma ”. 2022. AMJ (Advanced Medical Journal) 6 (2): 160-71. https://doi.org/10.56056/amj.2022.147.